Parkside Financial Bank & Trust’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.04K | Buy |
283
+20
| +8% | +$356 | ﹤0.01% | 1700 |
|
|
2025
Q1 | $4.69K | Buy |
263
+30
| +13% | +$535 | ﹤0.01% | 1649 |
|
|
2024
Q4 | $6.94K | Hold |
233
| – | – | ﹤0.01% | 1384 |
|
|
2024
Q3 | $3.64K | Sell |
233
-49
| -17% | -$766 | ﹤0.01% | 1491 |
|
|
2024
Q2 | $4.83K | Buy |
282
+84
| +42% | +$1.44K | ﹤0.01% | 1379 |
|
|
2024
Q1 | $3.1K | Sell |
198
-17
| -8% | -$266 | ﹤0.01% | 1438 |
|
|
2023
Q4 | $3.21K | Buy |
215
+145
| +207% | +$2.17K | ﹤0.01% | 1407 |
|
|
2023
Q3 | $1.13K | Buy |
70
+62
| +775% | +$1K | ﹤0.01% | 1810 |
|
|
2023
Q2 | $332 | Sell |
8
-36
| -82% | -$1.49K | ﹤0.01% | 1929 |
|
|
2023
Q1 | $2.65K | Sell |
44
-2
| -4% | -$120 | ﹤0.01% | 1612 |
|
|
2022
Q4 | $3.37K | Hold |
46
| – | – | ﹤0.01% | 1486 |
|
|
2022
Q3 | $3K | Sell |
46
-4
| -8% | -$261 | ﹤0.01% | 1433 |
|
|
2022
Q2 | $3K | Buy |
50
+12
| +32% | +$720 | ﹤0.01% | 1462 |
|
|
2022
Q1 | $3K | Buy |
38
+5
| +15% | +$395 | ﹤0.01% | 1506 |
|
|
2021
Q4 | $2K | Buy |
33
+24
| +267% | +$1.46K | ﹤0.01% | 1633 |
|
|
2021
Q3 | $1K | Sell |
9
-34
| -79% | -$3.78K | ﹤0.01% | 1689 |
|
|
2021
Q2 | $10K | Buy |
43
+35
| +438% | +$8.14K | ﹤0.01% | 971 |
|
|
2021
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 1508 |
|
|
2020
Q4 | $2K | Buy |
8
+4
| +100% | +$1K | ﹤0.01% | 1431 |
|
|
2020
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 1611 |
|